POSTOPERATIVE AUTOLOGOUS TRANSFUSION IN CARDIAC-SURGERY - A PROSPECTIVE, RANDOMIZED STUDY

To investigate the safety and efficacy of postoperative autologous blood transfusion (AT) using the Shiley hardshell venous reservoir, a prospective, randomised, controlled study was carried out in two matched groups of twenty patients undergoing elective coronary artery bypass surgery. The mean volume of shed mediastinal blood reinfused in the first 6 h postoperatively was 371.7 ± 63.23 ml. Use of homologous blood was reduced from 760.5 ± 108.37 ml in the control patients to 466.25 ± 87.44 ml in the AT patients, a reduction of 38.7% (p < 0.05). Therewas no statistically significant difference in the clinical outcome, overall blood loss, use of platelets, fresh frozen plasma and colloids, haematological indices, renal and hepatic functions, or clotting mechanism, although there was a reduction in the fibrinogen level in the patients who received AT (p < 0.05). Mediastinal blood did not clot and was defibrinogenated. It contained significant levels of haemoglobin (8.175 ± 0.506 g/dl), platelets (96.55 ± 10.39 per mm3 10mm3), protein (42.5 ± 1.13 g/l), calcium (2.385 ± 0.054 mmol/l) and was well oxygenated (PO20 = 20.46 ± 0.81 kPa). No patients developed bacteraemia or had any AT-related infections. We conclude that postoperative autologous transfusion using the Shiley hardshell venous reservoir is a safe and efficient method for reducing postoperative homologous blood requirement after coronary artery bypass surgery. © Springer-Verlag.